Related references
Note: Only part of the references are listed.EspC forms a filamentous structure in the cell envelope of Mycobacterium tuberculosis and impacts ESX-1 secretion
Ye Lou et al.
MOLECULAR MICROBIOLOGY (2017)
Novel approaches to tuberculosis vaccine development
Stefan H. E. Kaufmann et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2017)
Recombinant BCG Expressing ESX-1 of Mycobacterium marinum Combines Low Virulence with Cytosolic Immune Signaling and Improved TB Protection
Matthias I. Groeschel et al.
CELL REPORTS (2017)
Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study
Jason R. Andrews et al.
LANCET RESPIRATORY MEDICINE (2017)
Mycobacterium tuberculosis lineage 4 comprises globally distributed and geographically restricted sublineages
David Stucki et al.
NATURE GENETICS (2016)
MTBVAC vaccine is safe, immunogenic and confers protective efficacy against Mycobacterium tuberculosis in newborn mice
Nacho Aguilo et al.
TUBERCULOSIS (2016)
Tuberculosis Susceptibility and Vaccine Protection Are Independently Controlled by Host Genotype
Clare M. Smith et al.
MBIO (2016)
A Quantitative Analysis of Complexity of Human Pathogen-Specific CD4 T Cell Responses in Healthy M. tuberculosis Infected South Africans
Cecilia S. Lindestam Arlehamn et al.
PLOS PATHOGENS (2016)
Safety of human immunisation with a live-attenuated Mycobacterium tuberculosis vaccine: a randomised, double-blind, controlled phase I trial
Francois Spertini et al.
LANCET RESPIRATORY MEDICINE (2015)
A Specific Polymorphism in Mycobacterium tuberculosis H37Rv Causes Differential ESAT-6 Expression and Identifies WhiB6 as a Novel ESX-1 Component
Luis Solans et al.
INFECTION AND IMMUNITY (2014)
Evolutionary history of tuberculosis shaped by conserved mutations in the PhoPR virulence regulator
Jesus Gonzalo-Asensio et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Impact of in vitro evolution on antigenic diversity of Mycobacterium bovis bacillus Calmette-Guerin (BCG)
Richard Copin et al.
VACCINE (2014)
Hyper-attenuated MTBVAC erp mutant protects against tuberculosis in mice
Luis Solans et al.
VACCINE (2014)
The PhoP-Dependent ncRNA Mcr7 Modulates the TAT Secretion System in Mycobacterium tuberculosis
Luis Solans et al.
PLOS PATHOGENS (2014)
Systems infection biology: a compartmentalized immune network of pig spleen challenged with Haemophilus parasuis
Ming Zhao et al.
BMC GENOMICS (2013)
Recent developments in tuberculosis vaccines
Dessislava Marinova et al.
EXPERT REVIEW OF VACCINES (2013)
MprAB Regulates the espA Operon in Mycobacterium tuberculosis and Modulates ESX-1 Function and Host Cytokine Response
Xiuhua Pang et al.
JOURNAL OF BACTERIOLOGY (2013)
Genomic analysis of smooth tubercle bacilli provides insights into ancestry and pathoadaptation of Mycobacterium tuberculosis
Philip Supply et al.
NATURE GENETICS (2013)
Genome Sequencing and Analysis of BCG Vaccine Strains
Wen Zhang et al.
PLOS ONE (2013)
Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials
Ainhoa Arbues et al.
VACCINE (2013)
Risk of Progression to Active Tuberculosis Following Reinfection With Mycobacterium tuberculosis
Jason R. Andrews et al.
CLINICAL INFECTIOUS DISEASES (2012)
Phagosomal Rupture by Mycobacterium tuberculosis Results in Toxicity and Host Cell Death
Roxane Simeone et al.
PLOS PATHOGENS (2012)
A multistage tuberculosis vaccine that confers efficient protection before and after exposure
Claus Aagaard et al.
NATURE MEDICINE (2011)
Rv3615c is a highly immunodominant RD1 (Region of Difference 1)-dependent secreted antigen specific for Mycobacterium tuberculosis infection
Kerry A. Millington et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Suboptimal Activation of Antigen-Specific CD4+ Effector Cells Enables Persistence of M. tuberculosis In Vivo
Tyler D. Bold et al.
PLOS PATHOGENS (2011)
Secreted Immunodominant Mycobacterium tuberculosis Antigens Are Processed by the Cytosolic Pathway
Jeff E. Grotzke et al.
JOURNAL OF IMMUNOLOGY (2010)
MVA.85A Boosting of BCG and an Attenuated, phoP Deficient M. tuberculosis Vaccine Both Show Protective Efficacy Against Tuberculosis in Rhesus Macaques
Frank A. W. Verreck et al.
PLOS ONE (2009)
Control of M-tuberculosis ESAT-6 secretion and specific T cell recognition by PhoP
Wafa Frigui et al.
PLOS PATHOGENS (2008)
Genome plasticity of BCG and impact on vaccine efficacy
Roland Brosch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Recombineering in Mycobacterium tuberculosis
Julia C. van Kessel et al.
NATURE METHODS (2007)
Expression levels of Mycobacterium tuberculosis antigen-encoding genes versus production levels of antigen-specific T cells during stationary level lung infection in mice
Brian J. Rogerson et al.
IMMUNOLOGY (2006)
The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs
C Martin et al.
VACCINE (2006)
A non-RD1 gene cluster is required for Snm secretion in Mycobacterium tuberculosis
JA MacGurn et al.
MOLECULAR MICROBIOLOGY (2005)
Mutually dependent secretion of proteins required for mycobacterial virulence
SM Fortune et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
New live mycobacterial vaccines: the Geneva consensus on essential steps towards clinical development
AT Kamath et al.
VACCINE (2005)
A mycobacterial virulence gene cluster extending RD1 is required for cytolysis, bacterial spreading and ESAT-6 secretion
LY Gao et al.
MOLECULAR MICROBIOLOGY (2004)
Cytolytic CD8+ T cells recognizing CFP10 are recruited to the lung after Mycobacterium tuberculosis infection
AB Kamath et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis
AS Pym et al.
NATURE MEDICINE (2003)
A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis
MA Horwitz et al.
INFECTION AND IMMUNITY (2003)
Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti
AS Pym et al.
MOLECULAR MICROBIOLOGY (2002)
Conclusive evidence that the major T-cell antigens of the Mycobacterium tuberculosis complex ESAT-6 and CFP-10 form a tight, 1:1 complex and characterization of the structural properties of ESAT-6, CFP-10, and the ESAT-6-CFP-10 complex -: Implications for pathogenesis and virulence
PS Renshaw et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products
KA Datsenko et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)